AI-generated summary
The authors reviewed 35 studies of treatments for chemotherapy-induced peripheral neuropathy published from 1990 to 2017. They report moderate evidence of benefit for duloxetine and for photobiomodulation (low level laser therapy), while evidence did not support lamotrigine or topical ketamine-amitriptyline. Most included studies had small samples and short follow-up.
- Studies included
- 35
- Who or what was studied
- Patients with chemotherapy-induced peripheral neuropathy
- Limits stated in the abstract
- Included studies were small, had short follow-up, and varied widely in timing of treatment, primary outcomes, and chemotherapy agents used.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on pubmed.ncbi.nlm.nih.gov.
Record from PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Neuropathy, Systematic review, Laser, Photobiomodulation, Primary outcome, Risk of bias, GRADE. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.